Clinical Trials Browser

Completed × Glioma × Ondansetron × Clear all

NCT02991456 2023-07-11

Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide

Phase 2 Completed

48 enrolled 25 charts

Glioma, Nausea, Vomiting

NCT01450826 2018-06-26

Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide

Phase 2 Completed

136 enrolled 10 charts

Glioma, Nausea, Vomiting